EUVIMEDEUVIMED entdecken
Crossref

Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024

Luis Fernando Valladales-Restrepo iD, Ana Camila Delgado-Araujo, María Camila Oyuela-Gutiérrez, John Alexander López-Rincón, Andrés Gaviria-Mendoza iD, Manuel Enrique Machado-Duque iD, María Fernanda Hernández-Giraldo, Juan Pablo Albanes-Beltran, Jorge Enrique Machado-Alba iD

Pharmacoepidemiology and Drug Safety · 2026

DOI: 10.1002/pds.70366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2026. Verfasst von Luis Fernando Valladales-Restrepo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Drug Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

A pharmacotherapeutic follow‐up service is attended by pharmacists who systematically identify drug‐related problems and work to resolve their associated negative outcomes. The aim was to describe the characteristics of a pharmacotherapeutic follow‐up service and the factors associated with the presentation of drug‐related problems in a group of patients affiliated to the Colombian Health System.

Methods

This was a cross‐sectional study of patients who attended a DADER method‐based pharmacotherapeutic follow‐up service. The drug‐related problems and their associated negative outcomes as well as the interventions performed on the patients were identified. Descriptive analysis and binary logistic regression were performed considering the presence of drug‐related problems as a dependent variable ( p < 0.05).

Results

A total of 18 563 patients were identified, with an average age of 64.8 ± 14.9 years, and 66.3% were women. The most common chronic diseases were hypertension (54.3%), diabetes mellitus (29.2%), and rheumatoid arthritis (25.9%). The average number of medications/patient was 5.0 ± 4.1. Drug‐related problems were documented for 60.8% of the patients (1.6 drug‐related problems/patient), mainly due to drug–drug interactions (25.4%). Negative outcomes associated with medication use were observed for 60.0% of the patients (42.0% predominantly related to safety). The most common intervention was patient education (50.9%), and the negative outcomes associated with Medication use were resolved for 31.1% of patients who had two or more consultations. Patients over 65 years of age (OR:1.20; 95% CI:1.06–1.36), those from Bogotá–Cundinamarca (OR:1.62; 95% CI:1.52–1.73), those treated with ≥ 10 drugs (OR:1.21; 95% CI:1.07–1.36) and those treated with anticoagulants (OR:1.91; 95% CI:1.70–2.14) were more likely to experience drug‐related problems.

Conclusions

Drug‐related problems were frequently identified, with drug–drug interactions being the most prevalent problem. Drug‐related problems were associated with increased age, an increased number of prescribed medications and the use of anticoagulants. Safety‐related negative outcomes associated with medication use were common, education was the predominant intervention, and one‐third of the negative outcomes associated with medication use were resolved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsDrug MonitoringHumansCross-Sectional StudiesFemaleColombiaMaleMiddle AgedAgedAdultPharmacistsAged, 80 and over

Stichwörter der Autor:innen

colombiadrug‐related problemsmedication reviewpatient care managementpharmacovigilance

Autor:innen und Institutionen

  • Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.
  • Grupo de Investigación Biomedicina, Facultad de Medicina, Institución Universitaria Visión de las Américas, Pereira, Colombia.
  • Semillero de Investigación en Farmacología Geriátrica, Grupo de Investigación Biomedicina, Facultad de Medicina, Institución Universitaria Visión de las Américas, Pereira, Colombia.

ORCID-Profile: Luis Fernando Valladales-Restrepo, Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque, Jorge Enrique Machado-Alba

Zitieren

APA

Valladales-Restrepo, L. F., Delgado-Araujo, A. C., Oyuela-Gutiérrez, M. C., López-Rincón, J. A., Gaviria-Mendoza, A., Machado-Duque, M. E., Hernández-Giraldo, M. F., Albanes-Beltran, J. P., & Machado-Alba, J. E. (2026). Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70366

Vancouver

Valladales-Restrepo LF, Delgado-Araujo AC, Oyuela-Gutiérrez MC, López-Rincón JA, Gaviria-Mendoza A, Machado-Duque ME, et al. Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024. Pharmacoepidemiology and Drug Safety. 2026. doi:10.1002/pds.70366

BibTeX
@article{ValladalesRestrepo2026,
  author = {Valladales-Restrepo, Luis Fernando and Delgado-Araujo, Ana Camila and Oyuela-Gutiérrez, María Camila and López-Rincón, John Alexander and Gaviria-Mendoza, Andrés and Machado-Duque, Manuel Enrique and Hernández-Giraldo, María Fernanda and Albanes-Beltran, Juan Pablo and Machado-Alba, Jorge Enrique},
  title = {Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  doi = {10.1002/pds.70366}
}
Kostenlos starten →